Lumason Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0270-7097

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Lumason (NDC 0270-7097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bracco Diagnostics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lumason 5 Kit Market Unit Label (ce108503) Novaplus

Lumason is an injectable suspension containing sulfur hexafluoride, lipid-type A, and microspheres. It is intended for intravenous or intravesical use only after reconstitution. Each kit contains one vial of Lumason, one pre-filled Syringe containing sodium chloride injection, and one mini-spike. The kit components contain sulfur hexafluoride and various microspheres. The package insert provides recommended dosage and reconstitution instructions. The product is manufactured by Bracco Diagnostics and is for a single-use only.*

FDA Label Image

Lumason Kit Box Label (cf108404) Novaplus

Lumason is a medication available only on prescription, which comes in the form of a lyophilized powder for injectable suspension. It is made up of sulfur hexafluoride lipid-type A microspheres, with a content of 60.7mg of sulfur hexafluoride per vial, along with 25mg of lipid-type A. In addition, the Lumason pack contains a pre-filled syringe, containing 5mL of Sodium Chloride 0.8% Injection USP for use during reconstitution, as well as one mini-spike. NovaPlus is also mentioned, which appears to contain a pre-filled syringe with 5mg of polyethylene. There is a warning that Lumason is only suitable for intravenous or intravesical use and should not be used without reconstitution.*

FDA Label Image

Lumason Mp Box (cf116d02) Novaplus

Lumason is an injectable suspension containing sulfur hexafluoride lipid-type A microspheres. It is for intravenous or intravesical use only after reconstitution. Each vial contains sterile lyophilized powder of lipid-type A blend consisting of .19 mg distereaylphosphaticyichoine and .19 g dipaimitoylphosphatidyghyceral sodium, 2455 mg polyethylene glycol 000 and 0.4 mg paimitic acid. The headspace of the vial contains 807 mg sulfur hexafluoride. Each Lumason 20-vial pack contains 20 single-patient use vials of Lyumason lyophilized powder for injectable suspension, 507 mg sulfur hexafluoride/25 mg lipid-type A, and 20 mini spikes and D labels. The recommended dosage should be checked from the prescribed information. Store Lumason at 25°C with excursions permitted up to 15° to 30°C. The product is manufactured for Bracco Diagnostics Inc. by Bracco Suisse SA. The product is registered under the trademark Novaplus.*

FDA Label Image

Lumason Vial Label Kit (ci108303) Novaplus

Lumason is a prescription drug with the NDC number 0270-7099-73. It is administered via intravenous or intravesical use after reconstitution with Sodium Chioride 0.3% Injection, USP. The reconstituted solution has to be used within 3 hours of reconstitution. Lumason needs to be stored at 25°C with excursions permitted to 15°-30°C (56° to 86°F) and is for single use only. No additional information related to the drug's effectiveness or benefits has been mentioned.*

FDA Label Image

Lumason Vial Label Mp (ci116c02) Novaplus

Lumason® is a sulfur hexafluoride lipophilized powder for injectable suspension with NDC code 0270-7097-08. It is intended for intravenous or intravesical use after reconstitution with 0.9% Sodium Chloride Injection, USP. The reconstituted solution should be used for a single patient and any unused portion should be discarded within 3 hours. Lumason® should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Additional information such as date and time of the solution preparation, lot number, and expiration date is also provided.*

FDA Label Image

Empirical Formula 745

FDA Label Image

Empirical Formula 790 6

FDA Label Image

Figure1 Pack

FDA Label Image

Figure1 Single

FDA Label Image

Figure2 Pack

FDA Label Image

Figure2 Single

FDA Label Image

Figure3 Pack

FDA Label Image

Figure3 Single

FDA Label Image

Figure4 Pack

FDA Label Image

Figure4 Single

FDA Label Image

Figure5 Pack

FDA Label Image

Figure5 Single

FDA Label Image

Figure6 Pack

FDA Label Image

Figure6 Single

FDA Label Image

Figure7 Pack

FDA Label Image

Figure7 Single

FDA Label Image

Figure8 Single

FDA Label Image

Glass Vial Spike Labels

The text provides a list of medical items which includes 20 glass vials, 20 mini-spikes, and 20 peel-off syringe labels. The name "Lumason" is also mentioned, but no further context is provided.*

FDA Label Image

Glass Vial Spike Syringe And Rod

The text describes medical equipment including a glass vial, a prefilled syringe with diluent, a mini-spike, and a plunger rod. These items are specifically related to a product called Lumason.*

FDA Label Image

Novaplus Logo (Novaplus Logo)

FDA Label Image

Sulfur Hexafluoride Chemical Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.